- Reported transaction lines
- 3
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-113
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| KELLNER TED D Director · AIM ImmunoTech Inc. | AIM AIM ImmunoTech Inc. | Other transactionFiling detailsSEC transaction code D Common Stock · Indirect ownership · By Kellner,Ted Combined Profit Sharing/Money Purchase Plan · Reported balance after transaction: 0 · Shares held by the Kellner, Ted Combined Profit Sharing/Money Purchase Plan, for which the reporting person serves as trustee. | 2026-11-18 | 2026-11-20 | 250 shares/units | SEC 4 |
| KELLNER TED D Director · AIM ImmunoTech Inc. | AIM AIM ImmunoTech Inc. | Other transactionFiling detailsSEC transaction code D Common Stock · Indirect ownership · By Beta Fund Investment Club · Reported balance after transaction: 0 · Shares held by the Beta Fund Investment Club, for which the reporting person serves as the manager and is an investor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. | 2026-11-18 | 2026-11-20 | 2,702 shares/units | SEC 4 |
| KELLNER TED D Director · AIM ImmunoTech Inc. | AIM AIM ImmunoTech Inc. | Other transactionFiling detailsSEC transaction code D Common Stock · Indirect ownership · By Kelvest ILP · Reported balance after transaction: 19714 · Shares held by Kelvest I LP, for which the reporting person serves as Manager of T&M Partners LLC, General Partner of Kelvest I LP. | 2026-11-18 | 2026-11-20 | 14,574 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.